Filing Details

Accession Number:
0001562180-21-000346
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-14 20:14:20
Reporting Period:
2021-01-12
Accepted Time:
2021-01-14 20:14:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1404123 1Life Healthcare Inc ONEM Services-Offices & Clinics Of Doctors Of Medicine (8011) 760707204
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1642829 Dan Amir Rubin C/O 1Life Healthcare, Inc.
One Embarcadero Center, Suite 1900
San Francisco CA 94111
Chair, Ceo And President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-12 185,457 $4.01 434,834 No 4 M Direct
Common Stock Disposition 2021-01-12 185,457 $41.23 249,377 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-01-12 185,457 $0.00 185,457 $4.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,201,460 2027-09-13 No 4 M Direct
Footnotes
  1. The shares subject to the option vest as follows: 20% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/60th of the shares subject to the option vest monthly thereafter over the following four years, subject to reporting person's continuous service as of each such date.
  2. These trades were made pursuant to a Rule 10b5-1 trading plan with shares of common stock received upon concurrent exercises of stock options.
  3. This transaction was executed in multiple trades at prices ranging from $40.90 to $41.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.